相似文献
1
Gene Therapies for Neovascular Age-Related Macular Degeneration.
Cold Spring Harb Perspect Med. 2014 Dec 18;5(7):a017335. doi: 10.1101/cshperspect.a017335.
2
Development of gene therapy for treatment of age-related macular degeneration.
Acta Ophthalmol. 2014 Jul;92 Thesis3:1-38. doi: 10.1111/aos.12452.
3
Pegaptanib for the treatment of age-related macular degeneration.
Exp Eye Res. 2006 Sep;83(3):615-9. doi: 10.1016/j.exer.2006.02.010. Epub 2006 May 4.
4
[Guidance for the treatment of neovascular age-related macular degeneration (AMD)].
Przegl Lek. 2009;66(11):972-5.
5
Age-related macular degeneration.
Pharmacotherapy. 2013 Aug;33(8):838-55. doi: 10.1002/phar.1264. Epub 2013 Apr 11.
6
Comprehensive Preclinical Assessment of ADVM-022, an Intravitreal Anti-VEGF Gene Therapy for the Treatment of Neovascular AMD and Diabetic Macular Edema.
J Ocul Pharmacol Ther. 2021 Apr;37(3):181-190. doi: 10.1089/jop.2021.0001.
7
IL-18 Immunotherapy for Neovascular AMD: Tolerability and Efficacy in Nonhuman Primates.
Invest Ophthalmol Vis Sci. 2015 Aug;56(9):5424-30. doi: 10.1167/iovs.15-17264.
8
Profile of conbercept in the treatment of neovascular age-related macular degeneration.
Drug Des Devel Ther. 2015 Apr 22;9:2311-20. doi: 10.2147/DDDT.S67536. eCollection 2015.
9
Anti-VEGF agents for age-related macular degeneration.
Expert Opin Ther Pat. 2010 Jan;20(1):103-18. doi: 10.1517/13543770902762885.
10
引用本文的文献
1
Age-Related Macular Degeneration: Role of Oxidative Stress and Blood Vessels.
Int J Mol Sci. 2021 Jan 28;22(3):1296. doi: 10.3390/ijms22031296.
2
Associations of microRNAs, Angiogenesis-Regulating Factors and CFH Y402H Polymorphism-An Attempt to Search for Systemic Biomarkers in Age-Related Macular Degeneration.
Int J Mol Sci. 2019 Nov 15;20(22):5750. doi: 10.3390/ijms20225750.
本文引用的文献
1
Long-term efficacy of ciliary muscle gene transfer of three sFlt-1 variants in a rat model of laser-induced choroidal neovascularization.
Gene Ther. 2013 Nov;20(11):1093-103. doi: 10.1038/gt.2013.36. Epub 2013 Jun 27.
2
Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration.
Ophthalmology. 2012 Dec;119(12):2537-48. doi: 10.1016/j.ophtha.2012.09.006. Epub 2012 Oct 17.
3
Reduction of choroidal neovascularization in mice by adeno-associated virus-delivered anti-vascular endothelial growth factor short hairpin RNA.
J Gene Med. 2012 Nov;14(11):632-41. doi: 10.1002/jgm.2678.
4
Safety and biodistribution of an equine infectious anemia virus-based gene therapy, RetinoStat(®), for age-related macular degeneration.
Hum Gene Ther. 2012 Sep;23(9):980-91. doi: 10.1089/hum.2012.008. Epub 2012 Aug 1.
5
Preclinical safety evaluation of subretinal AAV2.sFlt-1 in non-human primates.
Gene Ther. 2012 Oct;19(10):999-1009. doi: 10.1038/gt.2011.169. Epub 2011 Nov 10.
6
AAV5-mediated sFLT01 gene therapy arrests retinal lesions in Ccl2(-/-)/Cx3cr1(-/-) mice.
Neurobiol Aging. 2012 Feb;33(2):433.e1-10. doi: 10.1016/j.neurobiolaging.2011.01.009. Epub 2011 Mar 12.
7
Preclinical safety evaluation of AAV2-sFLT01- a gene therapy for age-related macular degeneration.
Mol Ther. 2011 Feb;19(2):326-34. doi: 10.1038/mt.2010.258. Epub 2010 Nov 30.
8
Inhibition of choroidal neovascularization in a nonhuman primate model by intravitreal administration of an AAV2 vector expressing a novel anti-VEGF molecule.
Mol Ther. 2011 Feb;19(2):260-5. doi: 10.1038/mt.2010.230. Epub 2010 Oct 26.
9
Equine infectious anemia viral vector-mediated codelivery of endostatin and angiostatin driven by retinal pigmented epithelium-specific VMD2 promoter inhibits choroidal neovascularization.
Hum Gene Ther. 2009 Jan;20(1):31-9. doi: 10.1089/hum.2008.046.
10
An essential role for RPE-derived soluble VEGF in the maintenance of the choriocapillaris.
Proc Natl Acad Sci U S A. 2009 Nov 3;106(44):18751-6. doi: 10.1073/pnas.0905010106. Epub 2009 Oct 19.
Zotero 插件